Published in AIDS Weekly, August 16th, 1999
Preliminary results from studies already underway at Gallo's Institute of Human Virology indicate that the chemically detoxified toxin is safe and immunogenic in healthy human volunteers.
The immunogen could be used both to treat and to prevent HIV infection, Gallo suggested.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.